United Kingdom
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
28.75%
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
2 |
-22.17%
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
3 |
-25.96%
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
4 |
-107.31%
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
5 |
-170.51%
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
6 |
-294.66%
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
7 |
-324.81%
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
8 |
-669.72%
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
9 |
-862.19%
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
10 |
-2,204.65%
|
Dec. 31, 2023 | USD 14.84 | -2.75% |
|
United Kingdom |
|
11 |
-9,145.51%
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
12 |
-12,272.26%
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
The Clinical Trials company in United Kingdom with the highest Net Income Margin is hVIVO plc (LSE: HVO.L) at 28.75%.
The Clinical Trials company in United Kingdom with the lowest Net Income Margin is Autolus Therapeutics plc (NasdaqGS: AUTL) at -12,272.26%.
The top 10 Clinical Trials companies in United Kingdom by Net Income Margin are hVIVO plc, Immunocore Holdings plc, Cambridge Cognition Holdings Plc, Avacta Group Plc, Silence Therapeutics plc, Mereo BioPharma Group plc, GENinCode plc, Bicycle Therapeutics plc, Verici Dx plc and Centessa Pharmaceuticals plc.
The bottom 10 Clinical Trials companies in United Kingdom by Net Income Margin are Autolus Therapeutics plc, Barinthus Biotherapeutics plc, Centessa Pharmaceuticals plc, Verici Dx plc, Bicycle Therapeutics plc, GENinCode plc, Mereo BioPharma Group plc, Silence Therapeutics plc, Avacta Group Plc and Cambridge Cognition Holdings Plc.